RGEN — Repligen
Median target
$185
calls from the last 12 months
Implied return
+3.8%
median target vs. price
Coverage
8 analysts · 8 calls
updated in the last 12 months
Consensus
7/1/0+7 net
Buy / Hold / Sell
Which analysts are behind RGEN's consensus?
See every current rating, price target and the analysts' track records for Repligen — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 8 analysts with calls on RGEN updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
RGEN elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-04 | Insiders | Loeillot OlivierChief Executive Officer | Insider sale | 3.0K sh @ $165.90 · planned trade | $504K |
| 2026-08-20 | Insiders | Loeillot OlivierChief Executive Officer | Insider sale | 5.4K sh @ $180.00 · planned trade | $977K |
| 2025-05-12 | Executive | Trump, Donald JPresident | Sale | REPLIGEN CORP | $1,001 - $150,005 |
| 2025-04-11 | Executive | Trump, Donald JPresident | Purchase | REPLIGEN CORP | $1,001 - $150,004 |
| 2025-04-04 | Executive | Trump, Donald JPresident | Purchase | REPLIGEN CORP | $15,001 - $500,004 |
More: insider activity · executive branch · trending